APO RESEARCH · REPORT
Sanger Sequencing Service
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Product & engineering
Understand the product.
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Selected research
Industry Research
Sanger Sequencing Service Industry Research Report 2026
Market perspective
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Global Sanger Sequencing Service key players include Eurofins, Thermofisher, Genewiz, Nucleics, SciGenom Labs, etc. Global top five manufacturers hold a share about 70%. United States is the largest market, with a share about 25%, followed by Europe and China, both with a share about 20 percent. In terms of product, PCR amplicons is the largest segment, with a share about 60%. And in terms of application, the largest application is Institutions, followed by Bioscience Companies, Hospitals.
Report Scope
Read the full market overview
This report quantifies the global Sanger Sequencing Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Sanger Sequencing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sanger Sequencing Service Market by Company
Source BioScience
GenScript
Thermofisher
Nucleics
GenHunter Corporation
LGC Limited
SciGenom Labs
Fasteris SA
CeMIA SA
Microsynth AG
QuintaraBio
Eurofins
Genewiz
Sanger Sequencing Service Segment by Type
Plasmid DNA
PCR Amplicons
Others
Sanger Sequencing Service Segment by Application
Bioscience Companies
Hospitals
Institutions
Sanger Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sanger Sequencing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid DNA
- PCR Amplicons
- Others
Applications
- Bioscience Companies
- Hospitals
- Institutions
Companies covered
- Source BioScience
- GenScript
- Thermofisher
- Nucleics
- GenHunter Corporation
- LGC Limited
- SciGenom Labs
- Fasteris SA
- CeMIA SA
- Microsynth AG
- QuintaraBio
- Eurofins
- Genewiz
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sanger Sequencing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Plasmid DNA
- 2.2.3 PCR Amplicons
- 2.2.4 Others
- 2.3 Sanger Sequencing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Bioscience Companies
- 2.3.3 Hospitals
- 2.3.4 Institutions
- 2.4 Assumptions and Limitations
3 Sanger Sequencing Service Breakdown Data by Type
- 3.1 Global Sanger Sequencing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Sanger Sequencing Service Forecasted Market Size by Type (2027-2032)
4 Sanger Sequencing Service Breakdown Data by Application
- 4.1 Global Sanger Sequencing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Sanger Sequencing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Sanger Sequencing Service Market Perspective (2021-2032)
- 5.2 Global Sanger Sequencing Service Growth Trends by Region
- 5.2.1 Global Sanger Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Sanger Sequencing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Sanger Sequencing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Sanger Sequencing Service Market Dynamics
- 5.3.1 Sanger Sequencing Service Industry Trends
- 5.3.2 Sanger Sequencing Service Market Drivers
- 5.3.3 Sanger Sequencing Service Market Challenges
- 5.3.4 Sanger Sequencing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Sanger Sequencing Service Players by Revenue
- 6.1.1 Global Top Sanger Sequencing Service Players by Revenue (2021-2026)
- 6.1.2 Global Sanger Sequencing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Sanger Sequencing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Sanger Sequencing Service Head Office and Area Served
- 6.4 Global Sanger Sequencing Service Players, Product Type & Application
- 6.5 Global Sanger Sequencing Service Manufacturers Established Date
- 6.6 Global Sanger Sequencing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Sanger Sequencing Service Market Size (2021-2032)
- 7.2 North America Sanger Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Sanger Sequencing Service Market Size by Country (2021-2026)
- 7.4 North America Sanger Sequencing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Sanger Sequencing Service Market Size (2021-2032)
- 8.2 Europe Sanger Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Sanger Sequencing Service Market Size by Country (2021-2026)
- 8.4 Europe Sanger Sequencing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Sanger Sequencing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Sanger Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Sanger Sequencing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Sanger Sequencing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Sanger Sequencing Service Market Size (2021-2032)
- 10.2 South America Sanger Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Sanger Sequencing Service Market Size by Country (2021-2026)
- 10.4 South America Sanger Sequencing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Sanger Sequencing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Sanger Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Sanger Sequencing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Sanger Sequencing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Source BioScience
- 12.1.1 Source BioScience Company Information
- 12.1.2 Source BioScience Business Overview
- 12.1.3 Source BioScience Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.1.4 Source BioScience Sanger Sequencing Service Product Portfolio
- 12.1.5 Source BioScience Recent Developments
- 12.2 GenScript
- 12.2.1 GenScript Company Information
- 12.2.2 GenScript Business Overview
- 12.2.3 GenScript Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.2.4 GenScript Sanger Sequencing Service Product Portfolio
- 12.2.5 GenScript Recent Developments
- 12.3 Thermofisher
- 12.3.1 Thermofisher Company Information
- 12.3.2 Thermofisher Business Overview
- 12.3.3 Thermofisher Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.3.4 Thermofisher Sanger Sequencing Service Product Portfolio
- 12.3.5 Thermofisher Recent Developments
- 12.4 Nucleics
- 12.4.1 Nucleics Company Information
- 12.4.2 Nucleics Business Overview
- 12.4.3 Nucleics Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.4.4 Nucleics Sanger Sequencing Service Product Portfolio
- 12.4.5 Nucleics Recent Developments
- 12.5 GenHunter Corporation
- 12.5.1 GenHunter Corporation Company Information
- 12.5.2 GenHunter Corporation Business Overview
- 12.5.3 GenHunter Corporation Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.5.4 GenHunter Corporation Sanger Sequencing Service Product Portfolio
- 12.5.5 GenHunter Corporation Recent Developments
- 12.6 LGC Limited
- 12.6.1 LGC Limited Company Information
- 12.6.2 LGC Limited Business Overview
- 12.6.3 LGC Limited Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.6.4 LGC Limited Sanger Sequencing Service Product Portfolio
- 12.6.5 LGC Limited Recent Developments
- 12.7 SciGenom Labs
- 12.7.1 SciGenom Labs Company Information
- 12.7.2 SciGenom Labs Business Overview
- 12.7.3 SciGenom Labs Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.7.4 SciGenom Labs Sanger Sequencing Service Product Portfolio
- 12.7.5 SciGenom Labs Recent Developments
- 12.8 Fasteris SA
- 12.8.1 Fasteris SA Company Information
- 12.8.2 Fasteris SA Business Overview
- 12.8.3 Fasteris SA Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.8.4 Fasteris SA Sanger Sequencing Service Product Portfolio
- 12.8.5 Fasteris SA Recent Developments
- 12.9 CeMIA SA
- 12.9.1 CeMIA SA Company Information
- 12.9.2 CeMIA SA Business Overview
- 12.9.3 CeMIA SA Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.9.4 CeMIA SA Sanger Sequencing Service Product Portfolio
- 12.9.5 CeMIA SA Recent Developments
- 12.10 Microsynth AG
- 12.10.1 Microsynth AG Company Information
- 12.10.2 Microsynth AG Business Overview
- 12.10.3 Microsynth AG Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.10.4 Microsynth AG Sanger Sequencing Service Product Portfolio
- 12.10.5 Microsynth AG Recent Developments
- 12.11 QuintaraBio
- 12.11.1 QuintaraBio Company Information
- 12.11.2 QuintaraBio Business Overview
- 12.11.3 QuintaraBio Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.11.4 QuintaraBio Sanger Sequencing Service Product Portfolio
- 12.11.5 QuintaraBio Recent Developments
- 12.12 Eurofins
- 12.12.1 Eurofins Company Information
- 12.12.2 Eurofins Business Overview
- 12.12.3 Eurofins Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.12.4 Eurofins Sanger Sequencing Service Product Portfolio
- 12.12.5 Eurofins Recent Developments
- 12.13 Genewiz
- 12.13.1 Genewiz Company Information
- 12.13.2 Genewiz Business Overview
- 12.13.3 Genewiz Revenue in Sanger Sequencing Service Business (2021-2026)
- 12.13.4 Genewiz Sanger Sequencing Service Product Portfolio
- 12.13.5 Genewiz Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst